These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 21858659)
1. Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society. Ahn SH; Kim HJ; Lee JW; Gong GY; Noh DY; Yang JH; Jung SS; Park HY Breast Cancer Res Treat; 2011 Nov; 130(2):507-15. PubMed ID: 21858659 [TBL] [Abstract][Full Text] [Related]
2. Lymph node ratio as an alternative to pN staging in node-positive breast cancer. Vinh-Hung V; Verkooijen HM; Fioretta G; Neyroud-Caspar I; Rapiti E; Vlastos G; Deglise C; Usel M; Lutz JM; Bouchardy C J Clin Oncol; 2009 Mar; 27(7):1062-8. PubMed ID: 19164210 [TBL] [Abstract][Full Text] [Related]
3. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality. Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K J BUON; 2015; 20(3):737-45. PubMed ID: 26214625 [TBL] [Abstract][Full Text] [Related]
4. Lymph node ratio should be considered for incorporation into staging for breast cancer. Chagpar AB; Camp RL; Rimm DL Ann Surg Oncol; 2011 Oct; 18(11):3143-8. PubMed ID: 21847696 [TBL] [Abstract][Full Text] [Related]
5. Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series. Truong PT; Lesperance M; Li KH; MacFarlane R; Speers CH; Chia S Ann Surg Oncol; 2010 Aug; 17(8):2138-46. PubMed ID: 20151215 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of lymph node ratio in poor prognosis node-positive breast cancer patients in Saudi Arabia. Ibrahim EM; Elkhodary TR; Zekri JM; Bahadur Y; El-Sayed ME; Al-Gahmi AM; Rizvi SA; Hassouna AH; Fawzy EE; Awadalla SS Asia Pac J Clin Oncol; 2010 Jun; 6(2):130-7. PubMed ID: 20565426 [TBL] [Abstract][Full Text] [Related]
7. Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients. Schiffman SC; McMasters KM; Scoggins CR; Martin RC; Chagpar AB J Am Coll Surg; 2011 Jul; 213(1):45-52; discussion 52-3. PubMed ID: 21601490 [TBL] [Abstract][Full Text] [Related]
8. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients]. Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316 [TBL] [Abstract][Full Text] [Related]
9. Lymph node counts and ratio in axillary dissections following neoadjuvant chemotherapy for breast cancer: a better alternative to traditional pN staging. Chen S; Liu Y; Huang L; Chen CM; Wu J; Shao ZM Ann Surg Oncol; 2014 Jan; 21(1):42-50. PubMed ID: 24013900 [TBL] [Abstract][Full Text] [Related]
10. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection]. Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465 [TBL] [Abstract][Full Text] [Related]
11. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261 [TBL] [Abstract][Full Text] [Related]
12. The prognostic value of lymph node ratio in node-positive breast cancer: a Dutch nationwide population-based study. Dings PJ; Elferink MA; Strobbe LJ; de Wilt JH Ann Surg Oncol; 2013 Aug; 20(8):2607-14. PubMed ID: 23536053 [TBL] [Abstract][Full Text] [Related]
13. Metastatic axillary lymph node ratio (LNR) is prognostically superior to pN staging in patients with breast cancer--results for 804 Chinese patients from a single institution. Xiao XS; Tang HL; Xie XH; Li LS; Kong YN; Wu MQ; Yang L; Gao J; Wei WD; Xie X Asian Pac J Cancer Prev; 2013; 14(9):5219-23. PubMed ID: 24175804 [TBL] [Abstract][Full Text] [Related]
14. Additional prognostic value of lymph node ratio over pN staging in different breast cancer subtypes based on the results of 1,656 patients. Ataseven B; Kümmel S; Weikel W; Heitz F; Holtschmidt J; Lorenz-Salehi F; Kümmel A; Traut A; Blohmer J; Harter P; du Bois A Arch Gynecol Obstet; 2015 May; 291(5):1153-66. PubMed ID: 25367604 [TBL] [Abstract][Full Text] [Related]
15. Lymph node ratio: a new feature for defining risk category of node-positive breast cancer patients. Yang C; Liu F; Li S; Li W; Zhai L; Ren M; Li Y; Lang R; Fan Y; Zhang X; Fu L Int J Surg Pathol; 2012 Dec; 20(6):546-54. PubMed ID: 22736300 [TBL] [Abstract][Full Text] [Related]
16. The lymph node ratio as prognostic factor in node-positive breast cancer. Voordeckers M; Vinh-Hung V; Van de Steene J; Lamote J; Storme G Radiother Oncol; 2004 Mar; 70(3):225-30. PubMed ID: 15064006 [TBL] [Abstract][Full Text] [Related]
17. Does the axillary lymph node ratio have any added prognostic value over pN staging for South East Asian breast cancer patients? Saxena N; Hartman M; Yip CH; Bhoo-Pathy N; Khin LW; Taib NA; Looi LM; Lim SE; Lee SC; Verkooijen HM PLoS One; 2012; 7(9):e45809. PubMed ID: 23029254 [TBL] [Abstract][Full Text] [Related]
18. Mediastinal downstaging after induction treatment is not a significant prognostic factor to select patients who would benefit from surgery: the clinical value of the lymph node ratio. Renaud S; Falcoz PE; Olland A; Reeb J; Santelmo N; Massard G Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):222-7. PubMed ID: 25413781 [TBL] [Abstract][Full Text] [Related]
19. Using the lymph nodal ratio to predict the risk of locoregional recurrence in lymph node-positive breast cancer patients treated with mastectomy without radiation therapy. Wu SG; Chen Y; Sun JY; Li FY; Lin Q; Lin HX; He ZY Radiat Oncol; 2013 May; 8():119. PubMed ID: 23672513 [TBL] [Abstract][Full Text] [Related]
20. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer? Wang J; Kulaylat M; Rockette H; Hassett J; Rajput A; Dunn KB; Dayton M Ann Surg; 2009 Apr; 249(4):559-63. PubMed ID: 19300237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]